Aug 2026· Journal of the National Cancer Institute. Monographs· Vol 2026 73, pp.
137-147
· 0 citations
Medicine
TL;DR
Broad implementation of primary HPV-based screening, including self-sampling, will improve cervical cancer prevention and inform many more women of their high-risk HPV-positive status, and development of high-risk HPV-targeted therapeutics could further accelerate declines in cervical cancer by clearing prevalent infections.
Human papillomavirus (HPV) is the primary etiological agent of cervical cancer, a disease that remains a major cause of cancer-related morbidity and mortality among women in Kenya despite the availability of highly effective prophylactic vaccines. This review examines the current evidence on HPV virology, vaccine immun...
The current structural, cultural, and programmatic determinants of HPV vaccination differences across EU member states are investigated to investigate vaccine hesitancy, cervical cancer prevalence, immigration, single-dose regimen adoption, parent support, physician recommendation practices, and school-based vaccinatio...
L. Dupont, J. Jackson· Trends in Public Health· 0 citations
Background: Human papillomavirus (HPV) infection is the primary etiology of cervical cancer and its immediate precursors, collectively known as cervical intraepithelial neoplasia (CIN). Although primary prevention via prophylactic vaccination and secondary screening have significantly reduced incidence, cervical cancer...
Wiktor Śliwiński, Jakub Mazur, M. Kosowski et al.· International Journal of Inn...· 0 citations
The HPV Prevention and Control Board convened its 18th technical meeting in Antwerp, Belgium (June 2025) to review the evidence on universal HPV vaccination and the role of anal cancer screening in the elimination of HPV-associated cancers. While HPV prevention has historically focused on cervical cancer in women, grow...
F. R. Burdier, L. Bruni, Anna R. Giuliano et al.· BMC Proceedings· 0 citations
Human papillomavirus (HPV) is the primary etiological factor responsible for the development of cervical cancer and several other anogenital malignancies. According to the World Health Organization, more than 95% of cervical cancer cases are associated with persistent infection caused by high-risk HPV types. Currently,...
A. Amanbekov, Z. Kurmanalieva, C. Stakeeva et al.· Bulletin of Science and Prac...· 0 citations
Human Papillomavirus (HPV) is a highly prevalent sexually transmitted infection associated with malignancies of the cervix, vulva, and vagina. While prophylactic vaccination with Gardasil®9 is FDA-approved through age 45, no clinical trials have evaluated its use in older adults who remain sexually active and at risk f...
Rachel Michel, Caitlin S. Stukel, M. Pearl et al.· Venereology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.